Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
3,685
3,685 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- CRN09682Phase 21 trial
Crinetics Pharmaceuticals Inc. · SST2-positive Neuroendocrine Neoplasms, Neuroendocrine Tumors, Neuroendocrine Neoplasm
- CRT-402Phase 21 trial
Myeloid Therapeutics · Autoimmune Diseases, Systemic Lupus Erythematosus, Systemic Scleroderma
- CS-002Phase 21 trial
Applied Biology, Inc. · Canities, Grey Hair
- CS2009Phase 21 trial
CStone Pharmaceuticals · Advanced Solid Tumors
- CS32582Phase 21 trial
Chipscreen Biosciences, Ltd. · Plaque Psoriasis
- CS5006Phase 21 trial
CStone Pharmaceuticals · Advanced Solid Tumors
- CSG452Phase 21 trial
Kowa Research Institute, Inc. · NASH
- CSL787Phase 21 trial
CSL Behring · Non-cystic Fibrosis Bronchiectasis
- CSL889Phase 21 trial
CSL Behring · Sickle Cell Disease Vaso-occlusive Crisis
- CST-3056Phase 21 trial
CuraSen Therapeutics, Inc. · Neurogenic Orthostatic Hypotension
- CSTI-500Phase 21 trial
ConSynance Therapeutics · Prader-Willi Syndrome
- CT041Phase 21 trial
CARsgen Therapeutics Co., Ltd. · Gastric Cancer, Pancreatic Cancer
- CT071Phase 21 trial
CARsgen Therapeutics Co., Ltd. · Multiple Myeloma, Primary Plasma Cell Leukemia
- CT3001Phase 21 trial
Crossignal Therapeutics, Inc. · Solid Tumor, Adult, Colorectal Cancer, Pancreatic Ductal Adenocarcinoma
- CT7439Phase 21 trial
Carrick Therapeutics Limited · Solid Malignancies
- CTAP101Phase 21 trial
OPKO Health, Inc. · CKD Stage 3, CKD Stage 4, Secondary Hyperparathyroidism
- CTH120Phase 21 trial
Connecta Therapeutics, S.L. · Fragile X Syndrome (FXS), Fragile X Syndrome
- CTO1681Phase 21 trial
CytoAgents, Inc. · Cytokine Release Syndrome
- CTS3497Phase 21 trial
CytosinLab Therapeutics Co., Ltd. · Solid Tumor, Lymphoma
- CTX-471Phase 21 trial
Compass Therapeutics · Neuroendocrine Neoplasm, Neuroendocrine Carcinomas, Neuroendocrine Tumors
- CTX-712Phase 21 trial
Chordia Therapeutics, Inc. · Acute Myeloid Leukemia, Myelodysplastic Syndromes
- CTX340Phase 21 trial
CRISPR Therapeutics AG · Hypertension
- CTX460Phase 21 trial
CRISPR Therapeutics · Alpha-1 Antitrypsin Deficiency (AATD)
- CU01-1001Phase 21 trial
Curacle Co., Ltd. · Diabetic Nephropathies
- CU06-1004Phase 21 trial
Curacle Co., Ltd. · DME, Diabetic Macular Edema, Diabetic Macular Edema (DME)
- CX-011Phase 21 trial
CarthroniX, Inc. · Osteoarthritis of the Knees
- CYB004Phase 21 trial
Cybin IRL Limited · Generalized Anxiety Disorder
- CYT-0851Phase 21 trial
Cyteir Therapeutics, Inc. · Malignancy, Non-hodgkin Lymphoma, Multiple Myeloma
- CYT-1010Phase 21 trial
Cytogel Pharma, LLC · Acute Postoperative Pain, Dental Pain
- DA-020Phase 21 trial
Applied Biology, Inc. · Chemotherapy Induced Alopecia, Chemotherapy Side Effects
- DA-2811Phase 21 trial
Dong-A ST Co., Ltd. · Diabete Mellitus
- DA-2811-CPhase 21 trial
Dong-A ST Co., Ltd. · Diabete Mellitus
- DA-4505Phase 21 trial
Dong-A ST Co., Ltd. · Locally Advanced or Metastatic Solid Tumors
- DanvatirsenAZD9150Phase 21 trial
AstraZeneca · Non-Small Cell Lung Cancer
- DaplusiranTomligisiranPhase 21 trial
GSK · Chronic Hepatitis B Virus Infection, Hepatitis B
- DAT-2645Phase 21 trial
Danatlas Pharmaceuticals Co., Ltd · Advanced or Metastatic Ovarian Cancer
- DaxdilimabHZN-7734Phase 21 trial
Amgen · Idiopathic Inflammatory Myositis
- DB-1310Phase 21 trial
DualityBio Inc. · Advanced Solid Tumor
- DB-1324Phase 21 trial
DualityBio Inc. · Gastrointestinal Cancer
- DB-1419Phase 21 trial
DualityBio Inc. · Solid Tumor, Adult
- DB-2304Phase 21 trial
DualityBio Inc. · Systemic Lupus Erythematosus (SLE) or Cutaneous Lupus Erythematosus
- DC05F01Phase 21 trial
Heronova Pharmaceuticals · Solid Tumors, Ovarian Cancer, Small Cell Lung Cancer
- DCC-3009Phase 21 trial
Deciphera Pharmaceuticals, LLC · Gastrointestinal Stromal Tumor (GIST)
- DD01Phase 21 trial
Neuraly, Inc. · NAFLD, NASH
- Debio 1562MPhase 21 trial
Debiopharm International SA · Acute Myeloid Leukemia
- Debio 4228Phase 21 trial
Debiopharm International SA · Prostate Cancer
- Decoy20Phase 21 trial
Indaptus Therapeutics, Inc · Solid Tumor, Adult, HCC - Hepatocellular Carcinoma, CRC (Colorectal Cancer)
- DES-1357Phase 21 trial
D. E. Shaw Research, LLC · Metastatic Colorectal Cancer (CRC)
- DF1001Phase 21 trial
Dragonfly Therapeutics · Solid Tumor, Adult
- DF9001Phase 21 trial
Dragonfly Therapeutics · Solid Tumor, Adult
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.